|
Bisphosphonates
Citations 1-10 of 37 total displayed.
|
Most recent content
(1 Jun 2010):
|
- Perspectives
Nitrogen-Containing Bisphosphonates and Human   T Cells
- Ismahène Benzaid and Philippe Clézardin
IBMS BoneKEy 2010; 7: 208-217.
[Abstract]
[Full text]
[PDF]
|
Past content
(since Jan 2001):
|
- Commentaries
Bisphosphonates and Denosumab: Do They Thicken Bone Cortices, and Can These Changes Be Assessed by High-resolution pQCT?
- Serge Ferrari
IBMS BoneKEy 2010; 7: 182-186.
[Full text]
[PDF]
- MEETING REPORTS
Bone Therapeutics: Malignancy – Meeting Report from the IBMS Davos Workshop: Bone Biology & Therapeutics: March 14-19, 2010 in Davos, Switzerland
- Olivier Peyruchaud
IBMS BoneKEy 2010; 7: 193-196.
[Full text]
[PDF]
- Perspectives
Bisphosphonates and Fatigue Fractures
- Per Aspenberg
IBMS BoneKEy 2009; 6: 465-469.
[Abstract]
[Full text]
[PDF]
- MEETING REPORTS
Advances in Therapeutics: Meeting Report from the 31st Annual Meeting of the American Society for Bone and Mineral Research: September 11-15, 2009 in Denver, Colorado
- Ego Seeman
IBMS BoneKEy 2009; 6: 496-502.
[Full text]
[PDF]
- Perspectives
Interpretation of Randomized Controlled Trials of Fracture Prevention
- Tuan V. Nguyen
IBMS BoneKEy 2009; 6: 279-294.
[Abstract]
[Full text]
[PDF]
- Perspectives
Insights into the Antitumor Effects of Bisphosphonates from Preclinical Models and Potential Clinical Implications
- Philippe Clézardin
IBMS BoneKEy 2009; 6: 210-217.
[Abstract]
[Full text]
[PDF]
- Commentaries
Does Rat + Bisphosphonate + Exposed Bone = An Animal Model of ONJ?
- Matthew R. Allen
IBMS BoneKEy 2009; 6: 227-231.
[Full text]
[PDF]
- Commentaries
Should We Be Concerned About Giant Osteoclasts?
- Robert R. Recker
IBMS BoneKEy 2009; 6: 157-158.
[Full text]
[PDF]
- NEWS
Postoperative Management of Hip Fractures: Recent inaugural IBMS BoneKEy Online Forum focused on pharmacological and non-pharmacological approaches to managing patients post-hip fracture
- Neil A. Andrews
IBMS BoneKEy 2009; 6: 55-62.
[Full text]
[PDF]
|
|
